Latest filing published 22 Jan 2019 for Bionano Genomics, Inc., €6,847.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -75.7%Entry US$3,582.00 · Close at T+365 US$870.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark Borodkin: trading record in brief
Mark Borodkin discloses dealings in Bionano Genomics, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 23 August 2018 to 18 January 2019.
No open-market sale appears; the market trades are 1 purchase worth €4,328. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 option exercise.
Most recently, on 22 January 2019, the filings show an option exercise worth €6,847 in Bionano Genomics, Inc. The clock since the last published purchase (27 August 2018) now reads 2,996 days. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark Borodkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ US$1.3061.3% of flowCommon StockSEC:0001209191-19-004894:0
- 815 shares@ US$6.1338.7% of flowCommon StockSEC:0001209191-18-048558:0Canonical exit: 21 Nov 2018 (T+90)
2 of 2 declarations